Staphylococcal toxemia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:300579
Who is this for?
Show terms as
1Active trials22Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Staphylococcal toxemia is a serious condition caused by toxins produced by Staphylococcus bacteria, most commonly Staphylococcus aureus. Unlike a typical bacterial infection where the bacteria themselves cause direct damage, in staphylococcal toxemia the harm comes from powerful toxins (poisons) that the bacteria release into the bloodstream. These toxins can trigger a widespread and dangerous inflammatory response throughout the body. The condition can present in several forms, including toxic shock syndrome (TSS) and staphylococcal scalded skin syndrome, depending on which specific toxin is involved. Symptoms often come on suddenly and can include high fever, low blood pressure, a widespread rash that may look like a sunburn, confusion, muscle aches, vomiting, and diarrhea. In severe cases, the toxins can cause multiple organs to fail, which can be life-threatening. Treatment requires urgent medical care, typically involving intravenous antibiotics to kill the bacteria producing the toxins, aggressive fluid replacement to support blood pressure, and intensive care support for affected organs. Early recognition and rapid treatment are critical for survival. This is not a genetic or inherited condition — it is an infectious and toxin-mediated disease that can affect anyone, though certain risk factors such as wounds, surgical sites, tampon use, or weakened immune systems can increase susceptibility.

Key symptoms:

Sudden high feverVery low blood pressureWidespread red rash resembling sunburnSkin peeling, especially on palms and solesNausea and vomitingDiarrheaSevere muscle achesConfusion or disorientationHeadacheRedness of the eyes, mouth, or throatOrgan failure (kidneys, liver)Rapid heartbeatFeeling faint or dizzyExtreme fatigue and weakness

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

6 events
May 2025Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3

Assistance Publique - Hôpitaux de Paris — NA

TrialRECRUITING
Dec 2024A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

AstraZeneca — PHASE1, PHASE2

TrialRECRUITING
Jun 2024Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia

Clinical Research Centre, Malaysia — PHASE3

TrialRECRUITING
May 2024Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

Todd C. Lee MD MPH FIDSA — PHASE2

TrialRECRUITING
Sep 202318-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia

University College, London — NA

TrialNOT YET RECRUITING
Jun 2013Immune Resolution After Staphylococcus Aureus Bacteremia

University of Chicago

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Staphylococcal toxemia.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Phase 21 trial
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Phase 2
Actively Recruiting
PI: Todd C Lee, MD MPH FIDSA (Research Institute of the McGill University Health) · Sites: Calgary, Alberta; Hamilton, Ontario +3 more · Age: 18100 yrs

Specialists

22 foundView all specialists →
EM
Emily G McDonald, MD MSc
Specialist
PI on 3 active trials
MM
Matthew P Cheng, MD
Specialist
PI on 1 active trial
LM
Leonard Weisman, MD
HOUSTON, TX
Specialist
PI on 3 active trials1 Staphylococcal toxemia publication
EM
Eeva Ruotsalainen, MD
Specialist
PI on 1 active trial
JP
J D Smith, Ph.D.
Specialist
PI on 1 active trial
TF
Todd C Lee, MD MPH FIDSA
Specialist
PI on 3 active trials
MM
Michael Osthoff, PD Dr. med.
Specialist
PI on 5 active trials
SM
Seth Hetherington, M.D.
CHAPEL HILL, NC
Specialist
PI on 2 active trials
CP
Chi Hornik, PharmD
DURHAM, NC
Specialist
PI on 1 active trial
MM
Marc Engelhardt, MD
MANCHESTER, MO
Specialist
PI on 3 active trials
IM
Issam Raad, MD
HOUSTON, TX
Specialist
PI on 2 active trials1 Staphylococcal toxemia publication
JM
Jose M Cernadas, M.D.
Specialist
PI on 1 active trial
PM
Philip B Smith, MD
Specialist
PI on 1 active trial
XD
Xavier Duval
Specialist
PI on 1 active trial2 Staphylococcal toxemia publications
DM
Deborah Birx, MD
ATLANTA, GA
Specialist
PI on 1 active trial
VM
Vance G. Fowler, MD
DURHAM, NC
Specialist
PI on 1 active trial
JM
Jane de Lemos, MD
Specialist
PI on 1 active trial
DM
Daniel M Musher, MD
HOUSTON, TX
Specialist
PI on 1 active trial
PP
Phillipe BERTHELOT, MD PhD
Specialist
PI on 1 active trial
XP
Xavier Lescure, MD, PhD
Specialist
PI on 1 active trial
AG
Anna Goodman
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Staphylococcal toxemia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Staphylococcal toxemiaForum →

No community posts yet. Be the first to share your experience with Staphylococcal toxemia.

Start the conversation →

Latest news about Staphylococcal toxemia

Disease timeline:

New recruiting trial: A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

A new clinical trial is recruiting patients for Staphylococcal toxemia

New recruiting trial: Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia

A new clinical trial is recruiting patients for Staphylococcal toxemia

New recruiting trial: Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3

A new clinical trial is recruiting patients for Staphylococcal toxemia

New recruiting trial: Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

A new clinical trial is recruiting patients for Staphylococcal toxemia

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What type of staphylococcal toxin caused my illness, and does that affect my treatment?,How long will my recovery take, and what should I watch for during recovery?,Am I at risk for this happening again, and how can I reduce that risk?,Were any of my organs damaged, and will they recover fully?,Do I need to take any long-term medications or follow special precautions?,Should my family members be tested or treated for Staphylococcus bacteria?,When can I safely return to work, school, or normal activities?

Common questions about Staphylococcal toxemia

What is Staphylococcal toxemia?

Staphylococcal toxemia is a serious condition caused by toxins produced by Staphylococcus bacteria, most commonly Staphylococcus aureus. Unlike a typical bacterial infection where the bacteria themselves cause direct damage, in staphylococcal toxemia the harm comes from powerful toxins (poisons) that the bacteria release into the bloodstream. These toxins can trigger a widespread and dangerous inflammatory response throughout the body. The condition can present in several forms, including toxic shock syndrome (TSS) and staphylococcal scalded skin syndrome, depending on which specific toxin is

How is Staphylococcal toxemia inherited?

Staphylococcal toxemia follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Are there clinical trials for Staphylococcal toxemia?

Yes — 1 recruiting clinical trial is currently listed for Staphylococcal toxemia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Staphylococcal toxemia?

22 specialists and care centers treating Staphylococcal toxemia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.